PNAS Retracts Paper That Contributed to Lung Cancer Trial
A paper that was the subject of a four-page correction in 2018, and which helped inform a now-halted clinical trial […]
» Read moreHome »
The deadliest time in a viral respiratory illness sometimes is actually after the virus is cleared from the body. Destructive […] Pfizer recently announced that it is developing a booster dose of its Covid vaccine, with the specific intention of targeting […] In May 2020, a team led by thoracic surgeon Konrad Hoetzenecker of the Department of Surgery of MedUni Vienna and […] In May 2020, a team led by thoracic surgeon Konrad Hoetzenecker of the Department of Surgery of MedUni Vienna and […] Disruptions in the circadian rhythms in lung cells may explain why adults who survived premature birth are often more at […] Scientists are beginning to unravel one of the biggest challenges with immunotherapy: why some people with cancer respond to the […] Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come […] Computer scientists working with pathologists have trained an artificial intelligence (AI) tool to determine which patients with lung cancer have […] Mona Eskandari, an assistant professor of mechanical engineering at UC Riverside, is conducting research to combat lung damage due to […]
Why do short-lived lung infections lead to long-lasting lung damage?
A Lung Doctor Explains What to Know About Pfizers Upcoming COVID Vaccine Booster Shots
Criteria for selecting COVID-19 patients for lung transplantation
Criteria for selecting COVID-19 patients for lung transplantation
Disruption of lung biological clock in premature babies may raise later flu risk
Study identifies patients with lung cancer most likely to respond to immunotherapy
New drugs make headway against lung, prostate, colon cancers
AI could predict risk of lung cancer recurrence
COVID-19 highlights what we have yet to learn about lung mechanics
